Detalles de la búsqueda
1.
Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.
Cancer Sci
; 115(3): 1014-1021, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38263580
2.
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G).
Oncologist
; 29(3): e330-e336, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950903
3.
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
Int J Clin Oncol
; 28(6): 756-763, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36943545
4.
Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma.
Esophagus
; 20(2): 281-289, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484900
5.
TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III BRAF V600E-mutated colorectal cancer.
Future Oncol
; 18(38): 4153-4160, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36475784
6.
Myxoid liposarcoma originating in the retroperitoneum with metastasis to the calcaneus: a rare case report and review of literature.
Skeletal Radiol
; 51(10): 2053-2058, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35249148
7.
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
BMC Cancer
; 21(1): 1159, 2021 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715820
8.
Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center retrospective study.
Anticancer Drugs
; 32(1): 95-101, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32976215
9.
A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.
Int J Clin Oncol
; 26(4): 701-707, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33386556
10.
Clinical Impact of a Shortened Infusion Duration of Ramucirumab in Japanese Patients -A Model-Based Approach.
Gan To Kagaku Ryoho
; 48(11): 1381-1387, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34795131
11.
Phase I Study of Alternate-Day Administration of S-1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer.
Oncologist
; 25(11): e1614-e1620, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32490554
12.
Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer.
BMC Cancer
; 20(1): 338, 2020 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32316940
13.
A Prospective Trial Evaluating the Safety of a Shortened Infusion of Ramucirumab in Patients with Gastrointestinal Cancer.
Oncologist
; 24(2): 159-e66, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30305415
14.
Panitumumab Provides Better Survival Outcomes Compared to Cetuximab for Metastatic Colorectal Cancer Patients Treated with Prior Bevacizumab within 6 Months.
Oncology
; 96(3): 132-139, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30359979
15.
Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study.
Int J Clin Oncol
; 24(10): 1197-1203, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152323
16.
Correction: Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma.
Esophagus
; 20(2): 290, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36658273
17.
Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody.
Oncology
; 92(4): 205-212, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28142137
18.
[â ¡.BRAF-Mutated Colorectal Cancer-Up-to-Date Evidence and Clinical Practice].
Gan To Kagaku Ryoho
; 49(11): 1216-1220, 2022 11.
Artículo
en Japonés
| MEDLINE | ID: mdl-36412023
19.
Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study.
Target Oncol
; 18(5): 707-715, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37668815
20.
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study.
Front Immunol
; 14: 1325462, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38149256